ERBB2 and breast cancer: Since KCZ+BZA combination treatment synergistically suppresses viability and induces apoptosis in HER2-enriched breast cancer and TNBC cells in vitro, we next investigated if KCZ+BZA combination treatment could inhibit breast tumor progression.